✦ LIBER ✦

Subcutaneous methylnaltrexone improves bowel movement frequency and quality in patients with chronic non-malignant pain and opioid induced constipation

✍ Scribed by M. Duerden; A. Weil; D. Yu; S. Schulman; E. Tzanis; A. Manley; H. Zhang; B. Randazzo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous methylnaltrexone for the tr

✍ R. Blonsky; E. Michna; S. Schulman; E. Tzanis; A. Manley; H. Zhang; B. Randazzo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Subcutaneous methylnaltrexone does not e

✍ A. Weil; M. Duerden; S. Schulman; E. Tzanis; D. Yu; A. Manley; H. Zhang; B. Rand 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 36 KB

PG118 EFFECT OF SUBCUTANEOUS (SC) METHYL

✍ S Iyer; B Randazzo; E Tzanis; S Schulman; H Zhang; W Wang; A Manley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Opioid-induced bowel disorders and narco

✍ A. K. Tuteja; J. Biskupiak; G. J. Stoddard; A. G. Lipman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

Other: Opioid-induced bowel dysfunction:

✍ K. Fakata; A. Tuteja; A. Lipman; M. Ho 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB